Mechanical or metabolic treatment for coronary disease: synergistic, not antagonistic, approaches

Area of Science:

• Cardiology
• Vascular Medicine
• Pharmacology

Background:

• Traditional cardiology focuses on coronary artery narrowing, treating it with revascularization procedures like angioplasty.
• Percutaneous coronary interventions effectively alleviate angina and myocardial ischemia in stable coronary artery disease.
• However, these interventions do not prevent myocardial infarction or reduce overall mortality.

Purpose of the Study:

• To highlight the limitations of mechanical treatments for coronary artery disease.
• To emphasize the proven benefits of cholesterol-lowering therapy in reducing cardiovascular events and mortality.
• To advocate for a synergistic approach combining mechanical and metabolic interventions.

Main Methods:

• Review of large, randomized trials on cholesterol-lowering therapy.
• Analysis of outcomes data from percutaneous coronary interventions.
• Synthesis of evidence for combined treatment strategies.

Main Results:

• Cholesterol-lowering therapy significantly reduces mortality and coronary events.
• This therapy also decreases the need for revascularization procedures.
• Mechanical interventions alone do not improve long-term survival or prevent major adverse cardiac events.

Conclusions:

• A synergistic approach integrating mechanical and metabolic treatments is crucial for comprehensive coronary artery disease management.
• Cholesterol-lowering therapy offers mortality and morbidity benefits beyond symptom relief.
• Optimizing patient outcomes requires a dual strategy addressing both vessel blockages and underlying metabolic risk factors.